Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Week in Review: When TAVR valves fail | A new use for IVL | Semaglutide works fast | Obicetrapib in high-risk patients
Saturday, May 17, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

When valves fail: Surgeons share advice for treating high-risk patients with TAVR explant and SAVR

When a patient’s TAVR valve fails, redo TAVR is not always a feasible option. TAVR explantation and SAVR are typically the answer in these cases, but that approach is associated with certain risks. 

READ MORE >
According to the U.S. government, Asante Health System and one of its surgeons knowingly submitted false claims to Medicare, Medicaid and TRICARE for more than six years. Heart surgery surgeons.
Share on Twitter Share on Facebook Share on Linkedin

When valves fail: Surgeons share advice for treating high-risk patients with TAVR explant and SAVR

Share on Twitter Share on Facebook Share on Linkedin
According to the U.S. government, Asante Health System and one of its surgeons knowingly submitted false claims to Medicare, Medicaid and TRICARE for more than six years. Heart surgery surgeons.
When a patient’s TAVR valve fails, redo TAVR is not always a feasible option. TAVR explantation and SAVR are typically the answer in these cases, but that approach is associated with certain risks. 
READ MORE >

A new use for IVL: helping cardiologists secure transcarotid access for TAVR

IVL can do more than help prep patients for PCI. In fact, one heart team used Shockwave Medical's IVL technology to secure access for a high-risk TAVR patient.

READ MORE >
Intravascular lithotripsy IVL carotid artery TAVR. (A) Invasive angiography of the right common carotid artery. (B) Invasive angiography of the brachiocephalic artery (note the heavily calcified aortic arch). (C and D) Intravascular lithotripsy (IVL) treatment of the brachiocephalic artery to the mid common carotid artery using a 7.0 × 60 mm × 135 cm Shockwave IVL balloon. (E) Successful deployment of a 23 mm SAPIEN 3 Ultra 9750 TFX Aortic Valve. Images courtesy of JACC: Case Reports
Share on Twitter Share on Facebook Share on Linkedin

A new use for IVL: helping cardiologists secure transcarotid access for TAVR

Share on Twitter Share on Facebook Share on Linkedin
Intravascular lithotripsy IVL carotid artery TAVR. (A) Invasive angiography of the right common carotid artery. (B) Invasive angiography of the brachiocephalic artery (note the heavily calcified aortic arch). (C and D) Intravascular lithotripsy (IVL) treatment of the brachiocephalic artery to the mid common carotid artery using a 7.0 × 60 mm × 135 cm Shockwave IVL balloon. (E) Successful deployment of a 23 mm SAPIEN 3 Ultra 9750 TFX Aortic Valve. Images courtesy of JACC: Case Reports
IVL can do more than help prep patients for PCI. In fact, one heart team used Shockwave Medical's IVL technology to secure access for a high-risk TAVR patient.
READ MORE >

FDA gives AI-powered blood test for obstructive CAD breakthrough device designation

The FDA clearly sees significant potential in a new multi-protein blood test from Prevencio. The company's goal is to gain full approval and get the test in the hands of emergency departments all over the United States.

READ MORE >
blood test research laboratory
Share on Twitter Share on Facebook Share on Linkedin

FDA gives AI-powered blood test for obstructive CAD breakthrough device designation

Share on Twitter Share on Facebook Share on Linkedin
blood test research laboratory
The FDA clearly sees significant potential in a new multi-protein blood test from Prevencio. The company's goal is to gain full approval and get the test in the hands of emergency departments all over the United States.
READ MORE >

Cardiologist highlights safety, effectiveness of Boston Scientific TAVR valve

Andreas Ruck, MD, discussed new registry data on Boston Scientific’s Acurate neo2 TAVR valve, comparing it to popular devices from Edwards Lifesciences and Medtronic.

READ MORE >
Video interview with Andreas Ruck, MD, explaining a SWEDHEART registry comparison of Acurate Neo2 to Sapien and Evolut TAVR valves.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist highlights safety, effectiveness of Boston Scientific TAVR valve

Share on Twitter Share on Facebook Share on Linkedin
Video interview with Andreas Ruck, MD, explaining a SWEDHEART registry comparison of Acurate Neo2 to Sapien and Evolut TAVR valves.
Andreas Ruck, MD, discussed new registry data on Boston Scientific’s Acurate neo2 TAVR valve, comparing it to popular devices from Edwards Lifesciences and Medtronic.
READ MORE >

GE HealthCare debuts new wide-bore MRI scanner built with cardiology, oncology in mind

The new 1.5T MRI scanner includes a wide bore and key AI features designed to boost the patient experience.

READ MORE >
GE HealthCare SIGNA Sprint MRI
Share on Twitter Share on Facebook Share on Linkedin

GE HealthCare debuts new wide-bore MRI scanner built with cardiology, oncology in mind

Share on Twitter Share on Facebook Share on Linkedin
GE HealthCare SIGNA Sprint MRI
The new 1.5T MRI scanner includes a wide bore and key AI features designed to boost the patient experience.
READ MORE >

Intra-annular TAVR valves from Edwards Lifesciences and Abbott deliver similar 1-year outcomes

Each valve was associated with certain benefits, but one-year outcomes were largely similar. 

READ MORE >
Edwards Lifesciences SAPIEN 3 Ultra TAVR valve
Share on Twitter Share on Facebook Share on Linkedin

Intra-annular TAVR valves from Edwards Lifesciences and Abbott deliver similar 1-year outcomes

Share on Twitter Share on Facebook Share on Linkedin
Edwards Lifesciences SAPIEN 3 Ultra TAVR valve
Each valve was associated with certain benefits, but one-year outcomes were largely similar. 
READ MORE >

Semaglutide works fast, protecting the heart before weight loss kicks in

"These results highlight semaglutide’s early action on decreasing major cardiovascular events," one cardiologist explained.

READ MORE >
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

Semaglutide works fast, protecting the heart before weight loss kicks in

Share on Twitter Share on Facebook Share on Linkedin
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
"These results highlight semaglutide’s early action on decreasing major cardiovascular events," one cardiologist explained.
READ MORE >

Obicetrapib linked to substantial reductions in LDL cholesterol for high-risk heart patients

Researchers shared new studies on the highly selective CETP inhibitor in The New England Journal of Medicine and The Lancet.

READ MORE >
Cardiologist heart
Share on Twitter Share on Facebook Share on Linkedin

Obicetrapib linked to substantial reductions in LDL cholesterol for high-risk heart patients

Share on Twitter Share on Facebook Share on Linkedin
Cardiologist heart
Researchers shared new studies on the highly selective CETP inhibitor in The New England Journal of Medicine and The Lancet.
READ MORE >

FDA approves popular ultrasound enhancing agent for pediatric patients

Unlike other UEA options, GE HealthCare's Optison does not contain polyethylene glycol. The FDA approved its use for adult patients back in 1997.

READ MORE >
GE HealthCare Optison ultrasound enhancing agent used to enhance otherwise suboptimal echocardiograms and better show the borders of the chambers of the heart.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves popular ultrasound enhancing agent for pediatric patients

Share on Twitter Share on Facebook Share on Linkedin
GE HealthCare Optison ultrasound enhancing agent used to enhance otherwise suboptimal echocardiograms and better show the borders of the chambers of the heart.
Unlike other UEA options, GE HealthCare's Optison does not contain polyethylene glycol. The FDA approved its use for adult patients back in 1997.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup